Valuation: Acutaas Chemicals Limited

Market Cap 282B 2.94B 2.56B 2.42B 2.19B 4.11B 4.13B 28.95B 11.17B 143B 11.03B 10.78B 461B P/E 2027 *
62.2x
P/E 2028 * 46.2x
Enterprise Value 278B 2.89B 2.52B 2.38B 2.16B 4.05B 4.07B 28.54B 11.01B 141B 10.87B 10.63B 454B EV / Sales 2027 *
15.7x
EV / Sales 2028 * 11.8x
Free-Float
61.69%
Yield 2027 *
0.09%
Yield 2028 * 0.12%
1 day+3.78%
1 week+1.67%
Current month+8.85%
1 month+6.55%
3 months+5.98%
6 months+53.50%
Current year+101.79%
1 week 3,188.8
Extreme 3188.8
3,462
1 month 3,120
Extreme 3120
3,488
Current year 1,570
Extreme 1570
3,740
1 year 1,302
Extreme 1302
3,740
3 years 502.22
Extreme 502.225
3,740
5 years 383.05
Extreme 383.05
3,740
10 years 383.05
Extreme 383.05
3,740
Manager TitleAgeSince
Chief Executive Officer 52 2007-07-11
Director of Finance/CFO 48 2022-05-31
Chief Operating Officer - 2026-07-01
Director TitleAgeSince
Chairman 52 2007-07-11
Director/Board Member 52 2007-07-11
Director/Board Member 64 2018-04-22
Date Insider Type Main position Quantity % Market Cap. Importance
1/6/25 Buy

Director

2,000 0.0049%
1/6/25 Sell

Director

400 0.0010%
9/17/24 Sell 25,000 0.0611%
Change 5-day change 1-year change 3-year change Capi.($)
+3.78%+1.67%+135.94%+428.50% 2.94B
+1.42%+1.85%+26.17%+25.76% 69.24B
-1.43%-0.41%+20.55%+14.20% 50.96B
+1.33%+0.33%+3.15%+25.36% 16.68B
-0.74%+3.09%+34.79%+59.60% 13.72B
-2.30%+2.81%+34.32%+21.23% 10.29B
-1.45%-1.12%+17.30%-21.79% 9.92B
-1.09%-3.79%+13.18% - 9.04B
-2.41%-4.17%+90.82%-8.94% 8.68B
+0.99%+3.14%-12.82%+8.08% 7.91B
Average -0.19%+0.10%+36.34%+61.33% 19.94B
Weighted average by Cap. -0.06%+0.56%+25.67%+26.24%

Financials

2027 *2028 *
Net sales 17.69B 184M 161M 152M 138M 258M 259M 1.82B 702M 8.99B 692M 677M 28.93B 23.38B 244M 213M 201M 182M 341M 343M 2.4B 928M 11.89B 915M 895M 38.25B
Net income 4.53B 47.23M 41.19M 38.89M 35.32M 66.17M 66.44M 466M 180M 2.3B 177M 173M 7.41B 6.1B 63.53M 55.4M 52.31M 47.5M 89M 89.37M 627M 242M 3.1B 239M 233M 9.97B
Net Debt -3.97B -41.33M -36.04M -34.03M -30.9M -57.89M -58.13M -408M -157M -2.02B -155M -152M -6.49B -6.65B -69.26M -60.4M -57.03M -51.79M -97.03M -97.43M -683M -264M -3.38B -260M -254M -10.87B
Logo Acutaas Chemicals Limited
Acutaas Chemicals Limited, formerly Ami Organics Limited, is an India-based company, which is engaged in the manufacturing of pharma intermediates and specialty chemicals. It is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other industries. It manufactures pharma intermediates for certain active pharmaceutical ingredients (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It has developed and commercialized over 610 plus products, including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas.
Employees
1,007
Date Price Change Volume
26-09-18 ₹3,440.30 +3.78% 521,496
26-09-17 ₹3,315.10 -0.88% 182,520
26-09-16 ₹3,344.70 +2.40% 243,061
26-09-15 ₹3,266.20 -3.47% 264,234
26-09-11 ₹3,383.70 -1.96% 325,242
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
3,440.30INR
Average target price
3,140.90INR
Spread / Average Target
-8.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACUTAAS Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!